Results 121 to 130 of about 25,661 (241)

No lymphocytosis increase after cBTKi is a rare phenomenon except for CD49d-positive CLL mainly expressed in trisomy 12. [PDF]

Blood Adv
Laurenti L, Guglielmi F, Mosca A, Vitale C, Montalbano MC, Favrin G, Ferrarini I, Galitzia A, Pasquale R, Moratti M, Catania G, Murru R, Giannarelli D, Martino EA, Moia R, Zucchetto A, Tissino E, Autore F, Tomasso A, Stirparo L, Quaranta T, Abbate PL, Gattei V, Gaidano G, Gentile M, Krampera M, Farina G, Visentin A, Innao V, Varettoni M, Coscia M, Innocenti I.   +31 more
europepmc   +1 more source

Predicting Post-Radiotherapy Lymphocyte Recovery for Individualized Risk Stratification in Locally Advanced Esophageal Squamous Cell Carcinoma. [PDF]

Curr Oncol
Ji H, Su Y, Liu M, Wang Y, An Q, Jia Y, Zhang Z, Yan J, Bai J, Zhang P, Zhou Z.   +10 more
europepmc   +1 more source

Pre-discharge neutrophil:lymphocyte ratio and lymphopenia are associated with post-hospital long-term outcomes among survivors of critical illness. [PDF]

Intensive Care Med Exp
Marinho LL, Marshall JC, Jeong D, Ko DT, Lawler PR.   +4 more
europepmc   +1 more source

Real-World Incidence and Management of Non-Immune Effector Cell-Associated Neurotoxicity Syndrome Neurologic Events Following Ciltacabtagene Autoleucel in Multiple Myeloma. [PDF]

Clin Epidemiol
Hansen DK, Castaneda Puglianini OA, Grajales-Cruz A, Nagar SP, Ghosh S, Alegria V, De Braganca KC, Lengil T, Sharma M, Pai H, Perciavalle M, Maitland J, Emond B, Bixby T, Qureshi ZP, Janakiram M.   +15 more
europepmc   +1 more source

Impact of Frequent Immune‐Mediated Adverse Events on Treatment Continuity and Outcomes During Durvalumab Plus Tremelimumab Therapy for Unresectable Hepatocellular Carcinoma

Liver International Communications, Volume 7, Issue 2, June 2026.
ABSTRACT Durvalumab plus tremelimumab (Dur/Tre) is the first‐line treatment for unresectable hepatocellular carcinoma (uHCC). Immune‐mediated adverse events (imAEs) are common; however, the impact of specific imAE types on treatment persistence and outcomes remains unclear.
Tomomitsu Matono, Toshifumi Tada, Atsushi Hiraoka, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Tanaka, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Kazuhito Kawata, Atsushi Naganuma, Hisashi Kosaka, Hidekatsu Kuroda, Yutaka Yata, Hiroki Nishikawa, Michitaka Imai, Tomoko Aoki, Hironori Ochi, Hideyuki Tamai, Shohei Komatsu, Hideko Ohama, Fujimasa Tada, Shinichiro Nakamura, Kazuhiro Nouso, Asahiro Morishita, Norio Itokawa, Tomomi Okubo, Taeang Arai, Akemi Tsutsui, Takuya Nagano, Kazunari Tanaka, Takanori Matsuura, Yoshihide Ueda, Yuichi Koshiyama, Yuki Kanayama, Hidenao Noritake, Hirayuki Enomoto, Kosuke Matsui, Masaki Kaibori, Takumi Fukumoto, Yoichi Hiasa, Masatoshi Kudo, Takashi Kumada, on behalf of the RELPEC Group and HCC 48 Group   +53 more
wiley   +1 more source

The potential protective mechanisms of melatonin on alcoholic fatty liver disease based on the animal study. [PDF]

Front Vet Sci
Wu H, Zhu T, Guo F, Zhang L, Wang B, Liu G.   +5 more
europepmc   +1 more source

Phage Therapy as an Alternative Strategy Against Pseudomonas aeruginosa: A Narrative Review of Preclinical and Clinical Evidence

MicrobiologyOpen, Volume 15, Issue 3, June 2026.
Phage therapy shows promising efficacy against MDR, XDR, and PDR Pseudomonas aeruginosa infections across different models and administration routes. Evidence highlights reduced mortality, bacterial clearance, and synergy with antibiotics, while emphasizing the need for standardized protocols and advanced delivery systems to support clinical ...
Gustavo Aparecido da Cunha, Raine Piva Amaral, Ana Luisa Cauvila dos Santos, Bárbara Rafaela Ferreira Aio, Maria Fernanda Romboli Durante, Luiz Cosme Cotta Malaquias, Gabriel Magno de Freitas Almeida, Luiz Felipe Leomil Coelho   +7 more
wiley   +1 more source

Integrated transcriptomics and metabolomics reveal the effects of chronic alcohol consumption on periodontitis in rats. [PDF]

Front Immunol
Zhao Z, Zhao Z, Zhai Y, Sun J, Liu N, Liu Q.   +5 more
europepmc   +1 more source

K‐CC‐MoCo: A Fast k‐Space‐Based Respiratory Motion Correction for Highly Accelerated First‐Pass Perfusion Cardiovascular MR

Magnetic Resonance in Medicine, Volume 95, Issue 6, Page 3536-3549, June 2026.
ABSTRACT Purpose First‐pass perfusion cardiovascular MR (FPP‐CMR) enables the non‐invasive diagnosis of microcirculation and coronary artery disease. In free‐breathing FPP‐CMR, motion correction is usually performed in the image domain, requiring an initial reconstruction.
Elisa Moya‐Sáez, Rosa‐María Menchón‐Lara, Javier Sánchez‐González, Catarina N. Carvalho, Andreia S. Gaspar, Carlos Real, Carlos Galán‐Arriola, Rita G. Nunes, Borja Ibanez, Teresa M. Correia, Carlos Alberola‐López   +10 more
wiley   +1 more source

Sympatho‐Excitation in Pulmonary Hypertension: The Potential Role of Pulmonary Arterial Baroreceptors: An Acute Physiologic Intervention Study

Respirology, Volume 31, Issue 6, Page 621-629, June 2026.
Pulmonary arterial baroreceptors reflexively stimulate sympathetic nerve activity (SNA) in response to elevated pulmonary artery pressure and distension. In pulmonary hypertension patients, changes in muscle SNA were proportional to changes in pulmonary haemodynamics following nebulised iloprost.
Michael J. Plunkett, Ana L. C. Sayegh, Robert A. Lewis, Tanya J. McWilliams, Sasiharan Sithamparanathan, Julian F. R. Paton, James P. Fisher   +6 more
wiley   +1 more source